Latest News

- Malaria medication may help against one type of Frontotemporal Dementia

Munich/Bonn, 2md February 2011. Scientists at the German Center for Neurodegenerative Diseases (DZNE) and the Ludwig-Maximilians Universität Munich have found a promising approach for a possible treatment of so-called frontotemporal dementia, an Alzheimer-like form of…

Read more

- Humboldt Research Fellowship for scientist at the DZNE and University of Bonn

Zuzana Šišková, scientist in the group of Stefan Remy at the DZNE and the Department of Epileptology at the University Hospital of Bonn, received a Humboldt Research Fellowship for Postdoctoral Researchers. With the award, she will investigate how nerve cells change in…

Read more

- A molecular switch for memory and addiction

Scientists from Germany, UK and Italy identify a molecular switch that leads to a sustained increase of calcium in nerve cells and plays a crucial role in the formation of memory and addictive behaviors.

Read more

- Diabetes Drug could work against Alzheimer’s

Scientists from Berlin, Bonn and Dundee show in animal models that the diabetes drug Metformin has an effect against one of the main causes of the Alzheimer’s disease.

Read more

- Application of abnormal proteins outside the brain induces Alzheimer-like brain pathology in mice

Tübingen, 21.Oktober 2010.Pathological protein deposits linked to Alzheimer's disease and cerebral amyloid angiopathy can be triggered not only by the administration of pathogenic misfolded protein fragments directly into the brain but also by peripheral administration…

Read more

- Yokogawa and German Center for Neurodegenerative Diseases Sign Agreement on Joint Development of Drug Discovery Support System

Bonn/Tokyo, 20. Oktober 2010. Yokogawa Electric Corporation and the German Center for Neurodegenerative Diseases (DZNE) announce the signing of an agreement to cooperate in research and development activities to enhance the functions of the CellVoyagerTM CV6000 drug…

Read more

- First Announcement: The Hartwig Piepenbrock-DZNE Prize for exceptional contributions to research on neurodegenerative diseases

Bonn/Osnabrück, 21th September 2010. The Piepenbrock Group and the German Center for Neurodegenerative Diseases (DZNE) will jointly award a price amounting to 60.000 Euro to an individual whose research has significantly advanced our understanding of neurodegenerative…

Read more

- The DZNE is a "sunny" spot for scientists - an interview with Professor Donato Di Monte

Professor Di Monte, what made a renowned Parkinson’s researcher like you switch from sunny California to Bonn?
The definition of a “sunny place” for a scientist is where he/she has an opportunity to pursue research endeavours in a highly interactive environment and he/she is…

Read more

- New approach to Alzheimer’s therapy

DZNE and LMU researchers identify key target molecule

Read more

- Gemeinsam gegen neurodegenerative Erkrankungen

Deutsches Zentrum für Neurodegenerative Erkrankungen und Forschungszentrum Jülich kooperieren

Read more

Info-Hotline

Thursdays 1:30-4:30 pm

Patients +49 800-7799001

(free of charge)

Professionals +49 180-779900

(9 Cent/Min. German landline, mobile and out of Germany possibly more expensive)

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: